Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Firm demand driven by health consciousness and interest in sports activities, stronger relationships with business partners through consultative sales, expansion of the range of products handled under core brands, strengthened inventory flow management, and investment in labor-saving logistics
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥30,003 million (YoY +2.9%) |
| Operating profit | ¥655 million (YoY +27.1%) |
| Ordinary income | ¥772 million (YoY +23.0%) |
| Profit attributable to owners of the parent | ¥502 million (YoY +30.5%) |
| Net income per share | ¥25.67 |
| Equity ratio | End of the current fiscal period 48.5 / End of previous period 45.5 |
| Total assets | ¥32,118 million |
| Net assets | ¥15,565 million |
| Cash flows from operating activities | ¥643 million |
| Cash flows from investing activities | ¥-2,082 million |
| Cash flows from financing activities | ¥-423 million |
| Cash and cash equivalents at end of period | ¥6,746 million |
| Full-year earnings forecast | Net Sales ¥59,500 million (YoY +1.4%) / Operating profit ¥980 million (YoY -21.7%) / Ordinary income ¥1,200 million (YoY -17.9%) / Net income ¥830 million (YoY -14.9%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥18 → ¥18（0.0%） |
| Depreciation and amortization | ¥64 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies; removed: 0 companies (company names: —) |
| Material subsequent events | None |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 20,102,000 shares |
| Treasury Shares at Period-End | 527,253 shares |
| Factors Behind Changes in Business Performance | Firm demand driven by health consciousness and interest in sports activities, stronger relationships with business partners through consultative sales, expansion of the range of products handled under core brands, strengthened inventory flow management, and investment in labor-saving logistics |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to firm demand driven by health consciousness and interest in sports activities, as well as initiatives including consultative sales, expanding the range of products handled under core brands, strengthening inventory flow management, and investment in labor-saving logistics.